Clinical Chemistry
Glutamate a Promising New Biomarker for Prostate Cancer Aggressiveness
A team of investigators found that levels of serum glutamate, a naturally occurring nonessential amino acid that plays a key role in cancer metabolism, are increased in patients with primary and metastatic prostate cancer. More...30 Oct 2012
Gold Member
Automatic Hematology Analyzer
CF9600
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Thyroid Test
Anti-Thyroid EIA Test
In Other News
Blood Test Detects Early Stages of Cancer
Paper-Based Test Monitors Liver Damage
Treated Paper Suitable for Diagnostics
Breath Analysis Distinguishes Between Malignant and Benign Pulmonary Nodules
High Glucose Levels Predict Mortality in Pneumonia
Direct Mailing Improves Screening for Colorectal Cancer
Tests Combined for Early Diagnosis of Liver Disease
Single Step, Direct ELISA Measures Free Testosterone
Biomarker Levels Prognostic for Septic Patients
Protein Biomarker Predicts Cardiac Fibrosis Sequelae
Clot Protection Benefits Evaluated for New Blood Gas Testing System
Biosensor Detects Glucose in Saliva and Tears
Urine Test Predicts Risk of Bone Fracture
Blood Test Could Provide Earlier Diagnosis of Liver Disease
Hormone Levels Linked to Metabolic Disease
Blood Type Is a Risk Factor for Coronary Heart Disease
Blood Test Predicts Risk of Imminent Cardiac Episode
Heart Attack Test Delivers Results in One Hour
Total Cholesterol Determined from Photo of Patient's Hand
Multiple Sclerosis Detected by Analysis of Exhaled Breath
Blood Test for Prostate Cancer Reduces Mortality
LDH Levels Could Predict Kidney Cancer Response to Treatment
Neuropeptide Biomarker Differentiates Ischemic Stroke
The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.
